Cargando…
Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Group
A considerable subgroup of patients with early breast cancer does not address benefits of anthracycline based chemotherapy. The aim of this retrospective study was to investigate the effect of microvessel density (MVD) and status of p53 protein on 5-year disease free survival (DFS) in the group of b...
Autores principales: | Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448052/ https://www.ncbi.nlm.nih.gov/pubmed/22549273 http://dx.doi.org/10.1007/s12253-012-9525-9 |
Ejemplares similares
-
BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy
por: Biesaga, Beata, et al.
Publicado: (2014) -
Prognostic value of microvessel density in cervical cancer
por: Hu, Xiaoli, et al.
Publicado: (2018) -
Prognostic role of microvessel density in patients with glioma
por: Fan, Chaofeng, et al.
Publicado: (2019) -
Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015) -
Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma
por: Jureidini, Ricardo, et al.
Publicado: (2016)